# Probiotics in Patients With Primary Sclerosing Cholangitis

> **NCT00161148** · PHASE3 · UNKNOWN · sponsor: **UMC Utrecht** · enrollment: 12 (—)

## Conditions studied

- Primary Sclerosing Cholangitis

## Interventions

- **DRUG:** Probiotics

## Key facts

- **NCT ID:** NCT00161148
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 12 (—)
- **Last updated:** 2007-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161148, "Probiotics in Patients With Primary Sclerosing Cholangitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00161148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*